GlassScriptPhysician profile
Jennifer Lynn Stringer
NPI 1538753215
$648.72
in general payments reported to CMS, 2019-2025
15 companies · $40.85 in 2025
The $40.85 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.28 · 2022: $341 · 2023: $243 · 2025: $40.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.98 | 2022-2025 | |
| Amgen INC. | $55.78 | 2021-2022 | |
| Pfizer INC. | $49.40 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.60 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $33.13 | 2023 | Rexulti |
| Novo Nordisk INC | $31.95 | 2021-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.93 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.40 | 2025 | Lifevest |
| Mylan Specialty L.P. | $17.88 | 2023 | Yupelri |
| Ibsa Pharma INC. | $17.23 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.68 | 2022 | |
| Lundbeck LLC | $15.87 | 2023 | Rexulti |
| Lilly USA, LLC | $15.57 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.03 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.29 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.